Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of preparation method of rifampicin Ⅱ crystal form

A technology of rifampicin and crystal form, which is applied in the crystallization field of chemical engineering industry, can solve the problems of long cooling crystallization time, poor working environment, and small product particle size, and achieve the effect of large crystal particle size, uniform distribution, and increased bulk density

Active Publication Date: 2016-01-20
TIANJIN UNIV
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method has the disadvantage of long cooling and crystallization time
[0010] Electron micrographs of commercially available II crystal form rifampicin products are as follows: figure 1 As shown, the particle size of the product is small, and the crushing is serious. Its main particle size is about 70 μm, and its bulk density is 0.5 g / mL. The process method is to stand for a long time to cool and crystallize. poor environment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of rifampicin Ⅱ crystal form
  • A kind of preparation method of rifampicin Ⅱ crystal form
  • A kind of preparation method of rifampicin Ⅱ crystal form

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034]Dissolve 160 g of Form I rifampicin with a purity of 90% in 1000 mL of acetone under stirring, add 25 mL of water, and heat up to 57° C. to completely dissolve the rifampicin solid; then start vacuum evaporation with a vacuum of 0.01 MPa, and the solution The evaporation temperature is 55°C, and the evaporation rate is 200mL / hr. When the volume of the distillate reaches 500mL, the evaporation is stopped; the temperature is lowered to 10°C at a cooling rate of 4°C / h. The crystalline slurry was filtered, washed, and dried at 35°C for 3 hours to obtain 124.8 g of the crystal form II rifampicin product, with a yield of 78%.

[0035] The powder X-ray diffraction pattern of the product is as figure 2 As shown, there are characteristic peaks at diffraction angles 2θ of 4.62, 6.73, 7.48, 8.42, 9.47, 10.70, 12.21, 13.08, 13.94, 15.33, 16.51, 17.58, 19.57, 21.06, 22.73, 25.14, 25.92, 27.28 and 29.69 degrees . IR image 3 Shown at 773, 805, 838, 894, 971, 1000, 1019, 1044, 1096...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation method of a rifampicin II crystal form. The preparation method comprises the following steps: dissolving rifampicin crude materials with the purity being more than or equal to 90% in acetone, wherein the concentration of the solution is as follows: the ratio of rifampicin to acetone is equal to 0.08-0.24g / mL; adding water with the volume being 1-6% of the volume of the acetone, raising the temperature to 50-57 DEG C so as to completely dissolve rifampicin solid; adopting a vacuum evaporative crystallization to evaporate the rifampicin solution, and when the volume of the distilled liquid is 30-50% of the volume of the acetone, ending the evaporation; then adopting cooling crystallization, and reducing the temperature to 0-10 DEG C; and filtering, washing and drying crystal mush to obtain a rifampicin II crystal-form product. The yield in the crystallization process is more than 70%, the purity of crystal is more than 97%, the bulk density is more than 0.7g / mL, the average particle size reach more than 130mu m, and the filtering is easy. The preparation method disclosed by the invention has the advantages that the operation time is short, the seed crystal does not need to be added, the flowability of the product is good, the caking of crystal boards can be avoided, and the filtering time and the drying time are shortened, so that the application prospect is good.

Description

technical field [0001] The invention belongs to the technical field of chemical engineering industrial crystallization, and in particular relates to a preparation method of rifampicin II crystal form. Background technique [0002] Rifampicin, English name: Rifampicin, 3-(4-Methylpiperazinyliminomethyl)rifamycinSV; chemical name 3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin. Alias: Lifuping, Mepirifamycin, Rimidine, Molecular Formula C 43 h 58 N 4 o 12 , molecular weight 822.95, CAS number: 13292-46-1, the chemical structure is shown in the figure below. Rifampicin is bright red or dark red crystalline powder, tasteless and odorless, easily soluble in chloroform, soluble in methanol, almost insoluble in water. [0003] [0004] Rifampicin is an antibacterial drug that has high antibacterial activity against Mycobacterium tuberculosis, and has obvious antibacterial effects on Gram-positive bacteria and negative bacteria such as Neisseria meningitidis, Haemophilus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D498/08
CPCC07D498/08
Inventor 侯宝红井丁丁张美景王静康尹秋响鲍颖龚俊波陈巍周丽娜郝红勋
Owner TIANJIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products